Stockscreener 앱 받기
10.40
3.18%
-0.29
전일 마감가:
$10.69
열려 있는:
$10.61
하루 거래량:
93,055
Relative Volume:
0.04
시가총액:
$1.10B
수익:
$2.35B
순이익/손실:
$-74.42M
주가수익비율:
-11.06
EPS:
-0.94
순현금흐름:
$150.93M
1주 성능:
+10.81%
1개월 성능:
+3.60%
6개월 성능:
-56.09%
1년 성능:
-61.81%
1일 변동 폭
$10.33
$10.61
1주일 범위
$9.295
$10.95
52주 변동 폭
$8.23
$33.48
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
EVH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
10.40 | 1.10B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
235.36 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
58.70 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.27 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
89.19 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.49 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
1 Unprofitable Stock Worth Investigating and 2 to Question - Yahoo Finance
Evolent Health to Participate in Upcoming Conferences - Seeking Alpha
Evolent Health, Inc. (NYSE:EVH) Receives $17.71 Consensus Target Price from Brokerages - MarketBeat
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks - Yahoo Finance
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks - The Globe and Mail
Evolent Health, Inc. to Release First Quarter 2019 Operating Results and Host Conference Call on Tuesday, May 7, 2019 - BioSpace
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors - The Malaysian Reserve
Evolent Health Nominates Shawn Guertin to Board - TipRanks
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors | EVH Stock News - GuruFocus
Evolent Names Shawn Guertin As New Independent Nominee For Election To Its Board Of Directors - marketscreener.com
Healthcare Finance Veteran Shawn Guertin Brings 40-Year Experience to Evolent Board Nomination - Stock Titan
Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know - Yahoo Finance
Analysts’ Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) - The Globe and Mail
Evolent Health Insiders Placed Bullish Bets Worth US$1.35m - Yahoo
Evolent program achieves 20% reduction in use of low-value oncol - GuruFocus
Evolent program achieves 20% reduction in use of low-value oncology regimens - PR Newswire
Healthcare Breakthrough: Evolent Slashes Expensive Cancer Treatment Costs While Maintaining Care Quality - Stock Titan
Benign Growth For Evolent Health, Inc. (NYSE:EVH) Underpins Its Share Price - simplywall.st
Evolent To Release First Quarter 2025 Financial Results on Thurs - GuruFocus
Evolent Health (EVH) Price Target Lowered by Truist Analyst Amid Market Uncertainty | EVH Stock News - GuruFocus
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 - The Malaysian Reserve
The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts - Benzinga
1 Growth Stock to Stash and 2 to Keep Off Your Radar - The Globe and Mail
Evolent Health price target lowered to $14 from $15 at Truist - TipRanks
Truist Cuts Price Target on Evolent Health to $14 From $15, Keeps Buy Rating - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Medicare Advantage Rates Expected To Climb Over 5%: CMSAlignment Healthcare (NASDAQ:ALHC) - Benzinga
Analysts Set Evolent Health, Inc. (NYSE:EVH) Price Target at $17.71 - MarketBeat
KeyBanc sees PRVA acquisition of EVH’s MSSP as unlikely but instructive - Investing.com Australia
Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
Is Evolent Health (EVH) About to Explode? - Insider Monkey
12 Stocks That Are About to Explode - Insider Monkey
Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth - Insider Monkey
Evolent Health (NYSE:EVH) shareholders have endured a 69% loss from investing in the stock a year ago - Yahoo Finance
When the Price of (EVH) Talks, People Listen - Stock Traders Daily
1 Healthcare Stock on Our Watchlist and 2 to Turn Down - The Globe and Mail
Evolent Health (EVH): Among Stocks Insiders Are Buying In March - Insider Monkey
Evolent Health Co-Founder Acquires 13% More Stock - simplywall.st
10 Stocks Insiders Are Buying In March - Insider Monkey
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) - The Globe and Mail
Cardinal Health Adds Two Members to Its Board of Directors - HME Business
Commit To Buy Evolent Health At $7.50, Earn 22.1% Annualized Using Options - Nasdaq
Define Ventures Appoints Carolyn Magill as Venture Partner - Quantisnow
Healthcare Powerhouse Carolyn Magill Joins $800M Define Ventures Leadership Team - StockTitan
Evolent Health (NYSE:EVH) Given New $12.00 Price Target at JPMorgan Chase & Co. - Defense World
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of “Buy” from Analysts - Defense World
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.10%
0.12%
자본화:
|
볼륨(24시간):